[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20064398L - Kumarinderivat og anvendelse derav - Google Patents

Kumarinderivat og anvendelse derav

Info

Publication number
NO20064398L
NO20064398L NO20064398A NO20064398A NO20064398L NO 20064398 L NO20064398 L NO 20064398L NO 20064398 A NO20064398 A NO 20064398A NO 20064398 A NO20064398 A NO 20064398A NO 20064398 L NO20064398 L NO 20064398L
Authority
NO
Norway
Prior art keywords
ring
linear hydrocarbon
hydrocarbon group
carboxyl group
coumarin derivative
Prior art date
Application number
NO20064398A
Other languages
English (en)
Inventor
Hiroyuki Tawada
Shogo Marui
Masaki Ogino
Osamu Yabe
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20064398L publication Critical patent/NO20064398L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår et jordalkaliemetallsalt eller et organisk aminsalt av en forbindelse representert ved formel [I]: hvori R1 og R2 hver er et hydrogenatom, et halogenatom eller en eventuelt substituert lineær hydrokarbongruppe; ring A er en eventuelt ytterligere substituert benzenring; ring B er en eventuelt substituert benzenring; R er en karboksylgruppe eller en lineær hydrokarbongruppe substituert med en karboksylgruppe eller liknende.
NO20064398A 2004-03-02 2006-09-28 Kumarinderivat og anvendelse derav NO20064398L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004057920 2004-03-02
PCT/JP2005/003838 WO2005082879A1 (en) 2004-03-02 2005-03-01 Coumarin derivative and use thereof

Publications (1)

Publication Number Publication Date
NO20064398L true NO20064398L (no) 2006-11-08

Family

ID=34909071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064398A NO20064398L (no) 2004-03-02 2006-09-28 Kumarinderivat og anvendelse derav

Country Status (16)

Country Link
US (1) US7541478B2 (no)
EP (1) EP1720850A1 (no)
JP (1) JP2007526237A (no)
KR (1) KR20060130189A (no)
CN (1) CN1950352A (no)
AU (1) AU2005217335A1 (no)
BR (1) BRPI0508260A (no)
CA (1) CA2557162A1 (no)
CR (1) CR8577A (no)
IL (1) IL177105A0 (no)
NO (1) NO20064398L (no)
RU (1) RU2006134614A (no)
TW (1) TW200531969A (no)
UA (1) UA84052C2 (no)
WO (1) WO2005082879A1 (no)
ZA (1) ZA200606598B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920774B1 (fr) * 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
CN103833713B (zh) * 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iii型、其制法和其药物组合物与用途
CN112933101A (zh) * 2017-06-26 2021-06-11 上海日馨生物科技有限公司 苯磷硫胺衍生物、制备方法及其药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161530T1 (de) * 1992-09-04 1998-01-15 Takeda Chemical Industries Ltd Kondensierte heterozyklische verbindungen, deren herstellung und verwendung
CN1441794A (zh) 2000-07-13 2003-09-10 武田药品工业株式会社 富脂质斑退化剂
JP2002255808A (ja) 2000-07-13 2002-09-11 Takeda Chem Ind Ltd リピド・リッチ・プラーク退縮剤
NZ533893A (en) 2002-01-11 2006-06-30 Takeda Pharmaceutical Coumarin derivatives, process for their production and use thereof

Also Published As

Publication number Publication date
WO2005082879A1 (en) 2005-09-09
CA2557162A1 (en) 2005-09-09
CR8577A (es) 2007-01-17
ZA200606598B (en) 2008-02-27
KR20060130189A (ko) 2006-12-18
JP2007526237A (ja) 2007-09-13
CN1950352A (zh) 2007-04-18
IL177105A0 (en) 2006-12-10
BRPI0508260A (pt) 2007-07-31
TW200531969A (en) 2005-10-01
US7541478B2 (en) 2009-06-02
US20070197636A1 (en) 2007-08-23
AU2005217335A1 (en) 2005-09-09
EP1720850A1 (en) 2006-11-15
UA84052C2 (ru) 2008-09-10
RU2006134614A (ru) 2008-04-10

Similar Documents

Publication Publication Date Title
DK1740584T3 (da) Kondenseret chinolinderivat og anvendelse deraf
JO2791B1 (en) Acid secretion inhibitor
NO983970D0 (no) Tricykliske forbindelser, deres fremstilling og anvendelse
TW200727733A (en) Moisture-reactive composition and organic electroluminescent element having same
DE60322224D1 (de) Kondensierte heterozyklische verbindungen als petidase inhibitoren
AU2006232435A8 (en) BCRP/ABCG2 inhibitor
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
NO20083408L (no) Korrosjonsinhibitorer som har okt biologisk nedbrytbarhet og redusert giftighet
RS51654B (en) DERIVATIVES OF THE SUBSTITUTED BICYCLIC PIRIMIDONE
AR057088A1 (es) Compuestos quimicos
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
TW200510377A (en) Novel compound having 4-pyridylalkylthio group as substituent
TW200720222A (en) Hydrocarbon compound, charge-transporting material, charge-transporting material composition, and organic electroluminescent element
WO2003059900A1 (fr) Derives de coumarine, leur procede de production et d'utilisation
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
NO20064398L (no) Kumarinderivat og anvendelse derav
ATE446948T1 (de) Alpha-ketoamidderivativ, herstellungsverfahren und verwendung davon
DE60234117D1 (de) 2-amino-4-pyridylmethyl-thiazolinderivate und ihre verwendung als induzierbare no-synthase inhibitoren
DK1036793T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivat og 3-aminothiophenderivat
ATE399169T1 (de) Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase
ATE423171T1 (de) Verwendung von chinaldin-und naphthalinderivaten als kristallisationsmodifikatoren
TNSN06337A1 (en) 6-substituted pyridoindolone derivatives production and therapeutic use thereof
MY139258A (en) Carbamoyl-type benzofuran derivatives
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung
NO20045123L (no) Nitroserte imidazopyridiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application